<DOC>
	<DOC>NCT02785263</DOC>
	<brief_summary>The purpose of this study is to maximize patient involvement in the treatment of anal cancer. Specifically, the investigators will investigate whether patients wish to take part in the decision making on radiation dose and whether they want a high or low radiation dose.</brief_summary>
	<brief_title>Shared Decision Making With Anal Cancer Patients on Radiation Dose</brief_title>
	<detailed_description>The study will also provide new knowledge on the effect and side effects of irradiation of anal cancer, and detailed data from the dose planning will be instrumental in optimizing future decision aids.</detailed_description>
	<mesh_term>Anus Neoplasms</mesh_term>
	<criteria>Squamous cell carcinoma of the anal duct or perianal (nonhairy skin, max 5 cm from the anal verge) T2T4 N03 Age ≥ 18 years Performance status 02 Sufficient organ and bone marrow function defined as: Neutrophils ≥ 1.5 x 10^9/L Thrombocytes ≥ 100 x 10^9/L Curative intent radiation treatment deemed possible Patients chooses 1 of 3 options: I do not wish to decide on details of my treatment, but I would like to receive the standard treatment I want to receive the high radiation dose I want to receive the low radiation dose Written and orally informed consent Nonresectable metastases Tumor &gt; 10 cm or the total tumor volume (incl. lymph node metastases) is too large to be included in an appropriate radiation field (after possible neoadjuvant chemotherapy) Pregnant or breastfeeding women Fertile women not willing to use effective contraception Serious comorbidity that would hinder interfere with radiation treatment or hinder patient compliance (e.g. incapacity to understand or complete questionnaires)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Anal cancer</keyword>
	<keyword>Shared decision making</keyword>
</DOC>